Effect of kinesio taping in Parkinson's disease
- Conditions
- Parkinson's disease.
- Registration Number
- IRCT20191216045759N1
- Lead Sponsor
- The University of Lahore
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Idiopathic Parkinson’s disease clinically diagnosed by neurologist (according to the UK PDS Brain Bank criteria).
Both males and females; 50 - 80 years of age.
Modified Hoehn and Yahr stage 2.5 to 3
Movement Disorder Society-Unified Parkinson’s Disease Rating Scale III subscore ‘gait’ or ‘postural stability’ = 1
Receive a stable dopaminergic medication dose (both levo-dopa and/or a dopamine agonist are allowed) for one month before the study
A Mini Mental State Examination score < 24/30
Diagnosed with any other neurological disease other than PD
Patient underwent surgery i.e. deep brain stimulation and lesioning surgery (thalamotomy, pallidotomy, subthalamotomy)
Fixed vertebral deformities (ankylosing spondylitis, vertebral pathology such as fracture, spinal cord pathology such as syrinx, idiopathic or degenerative scoliosis).
Have severe cardiovascular or pulmonary problems
Have lower extremity disorders (e.g. deformities, fractures, rheumatologic disease and operations).
Visual or acoustic limitations
A major change in medicine existed during the training period
Any skin or allergic reaction to kinesio tape
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method